Prevalence of Mycobacterium lentiflavum in cystic fibrosis patients, France - Archive ouverte HAL Access content directly
Journal Articles BMC Pulmonary Medicine Year : 2015

Prevalence of Mycobacterium lentiflavum in cystic fibrosis patients, France

(1) , (2) , (1, 3) , (1, 3) , (2) , (1) , (1) , (1)
1
2
3

Abstract

Background: Mycobacterium lentiflavum is rarely isolated in respiratory tract samples from cystic fibrosis patients. We herein describe an unusually high prevalence of M. lentiflavum in such patients. Methods: M. lentiflavum, isolated from the respiratory tract of cystic fibrosis patients, was identified using both rpoB partial sequencing and detected directly in the sputum by using real-time PCR targeting the smpB gene. Results: M. lentiflavum emerged as the third most prevalent nontuberculous mycobacterial species isolated in cystic fibrosis patients in Marseille, France. Six such patients were all male, and two of them may have fulfilled the American Thoracic Society clinical and microbiological criteria for M. lentiflavum potential lung infection. Conclusions: M. lentiflavum was the third most common mycobacteria isolated in cystic fibrosis patients, particularly in six male patients. M. lentiflavum outbreaks are emerging particularly in cystic fibrosis patients.
Fichier principal
Vignette du fichier
s12890-015-0123-y.pdf (746.72 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

hal-01236255 , version 1 (01-12-2015)

Identifiers

Cite

Michael Phelippeau, Jean-Christophe Dubus, Martine Reynaud-Gaubert, Carine Gomez, Nathalie Stremler Le Bel, et al.. Prevalence of Mycobacterium lentiflavum in cystic fibrosis patients, France. BMC Pulmonary Medicine, 2015, 15 (131), ⟨10.1186/s12890-015-0123-y⟩. ⟨hal-01236255⟩
109 View
625 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More